EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phosphodiesterase 10A Inhibitor Modulates Right Ventricular Outflow Tract Electrophysiological Activities and Calcium Homeostasis via the cGMP / PKG Pathway

Feng-Zhi Lin, Yao-Chang Chen, Hsiang-Yu Yang iD, Wei-Shiang Lin, Yen-Yu Lu

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Feng-Zhi Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Institute of Physiology, National Defense Medical Center, Taipei, Taiwan. Hauptthemen laut MEDLINE: Calcium, Cyclic GMP, Heart Ventricles, Phosphodiesterase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of National Defense-Medical Affairs Bureau, Tri-Service General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphodiesterase inhibitors regulate intracellular Ca 2+ of cardiomyocytes through enhancing second messenger signalling. This study aimed to investigate whether TP‐10, a selective phosphodiesterase10A inhibitor, modulates Ca 2+ cycling, attenuating arrhythmogenesis in the right ventricular outflow tract (RVOT). Right ventricular tissues from New Zealand white rabbits were harvested, and electromechanical analyses of ventricular tissues were conducted. Intracellular Ca 2+ was monitored using Fluo‐3, and ionic current was recorded using patch‐clamp in isolated cardiomyocytes. Tissues from RVOT exhibited a reduction in action potential duration at both 50% and 90% repolarisation following treatment with TP‐10. This treatment also inhibited burst firing induced by isoproterenol (ISO) in RVOT tissues, an effect that was nullified by thapsigargin. The protein kinase G inhibitor KT5823, whether used alone or in conjunction with TP‐10, also suppressed ISO‐induced burst firing in these tissues. Compared to the control group, RVOT cardiomyocytes treated with TP‐10 demonstrated enhanced amplitudes of Ca 2+ transients and increased stores of Ca 2+ in the sarcoplasmic reticulum. Although the L‐type Ca 2+ current was diminished in TP‐10‐treated cardiomyocytes, the current from the Na + ‐Ca 2+ exchanger was elevated. Furthermore, the density of late Na + current was significantly reduced in these treated cardiomyocytes. TP‐10 administration also resulted in increased levels of calcium regulatory proteins, specifically phosphorylated phospholamban at Thr17 and sarcoplasmic/endoplasmic reticulum Ca 2+ ATPase 2a. Our findings indicate that TP‐10 attenuates ISO‐induced arrhythmic events in RVOT tissues via cGMP‐mediated modulation of intracellular Ca 2+ regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalciumCyclic GMPHeart VentriclesPhosphodiesterase InhibitorsCyclic GMP-Dependent Protein KinasesElectrophysiological PhenomenaPhosphoric Diester HydrolasesAnimalsRabbitsMyocytes, CardiacHomeostasisAction PotentialsSarcoplasmic ReticulumSignal TransductionIsoproterenolMaleCalcium Channels, L-TypeSodium-Calcium ExchangerCalcium-Binding ProteinsCarbazolesPhospholamban

Stichwörter der Autor:innen

Ca2+ regulationphosphodiesterase 10A inhibitorright ventricular outflow tract

Substanzen

CalciumCyclic GMPPhosphodiesterase InhibitorsCyclic GMP-Dependent Protein KinasesIsoproterenolCalcium Channels, L-TypePhosphoric Diester HydrolasesSodium-Calcium ExchangerCalcium-Binding ProteinsCarbazoles

Autor:innen und Institutionen

  • Department of Biomedical Engineering and Institute of Physiology, National Defense Medical Center, Taipei, Taiwan.
  • Grade Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
  • Department of Biochemistry, National Defense Medical Center, Taipei, Taiwan.
  • Division of Cardiovascular Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
  • Fu Jen Catholic University, School of Medicine, New Taipei City, Taiwan.

ORCID-Profile: Hsiang-Yu Yang

Förderung

  • Ministry of National Defense-Medical Affairs Bureau
  • Tri-Service General Hospital

Zitieren

APA

Lin, F. Z., Chen, Y. C., Yang, H. Y., Lin, W. S., & Lu, Y. Y. (2025). Phosphodiesterase 10A Inhibitor Modulates Right Ventricular Outflow Tract Electrophysiological Activities and Calcium Homeostasis via the cGMP / PKG Pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70480

Vancouver

Lin FZ, Chen YC, Yang HY, Lin WS, Lu YY. Phosphodiesterase 10A Inhibitor Modulates Right Ventricular Outflow Tract Electrophysiological Activities and Calcium Homeostasis via the cGMP / PKG Pathway. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70480

BibTeX
@article{Lin2025,
  author = {Lin, Feng-Zhi and Chen, Yao-Chang and Yang, Hsiang-Yu and Lin, Wei-Shiang and Lu, Yen-Yu},
  title = {Phosphodiesterase 10A Inhibitor Modulates Right Ventricular Outflow Tract Electrophysiological Activities and Calcium Homeostasis via the cGMP / PKG Pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70480}
}
Kostenlos starten →